Covid-19

Pfizer Shares Are Down Today: What's Going On?
'Black Swan' Hedge Fund Posts 4,000% Profits During COVID-19 Market Crash: Here's How
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients
'Black Swan' Hedge Fund Posts 4,000% Profits During COVID-19 Market Crash: Here's How
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients
Invivyd Touts Encouraging Data From COVID-19 Antibody Trial, Stock Jumps
Robert Kennedy Jr. Faces Senate Confirmation Hearings As Bird Flu Concerns Grow: Caroline Kennedy Says Cousin 'Predator' Unfit For Office

Covid-19 Recent News

Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped
On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. (NASDAQ:MRNA) and Square Inc. (NYSE:SQ). The Moderna Trade
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
On Wednesday, Cathie Wood’s Ark Invest made significant trades involving Block Inc (NYSE:SQ) and Moderna Inc (NASDAQ:MRNA). The SQ Trade
Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70.
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
On Thursday Oct 10, 2024 Cathie Wood-Led Ark Invest sold over $9 million worth of Moderna stock.
Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine
Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined. Both companies have agreed to dismiss the case without prejudice for possible future actions.
Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles
Gilead Sciences has recalled one lot of its COVID-19 treatment, Veklury (remdesivir), due to glass particles found in vials. Gilead is notifying distributors to cease use and return the remaining vials.
Harris Hit Trump With Claim Of 'Worst Unemployment Since The Great Depression' During Debate, Here Is What The Economists Said
In their first debate for the 2024 election, Vice President Kamala Harris criticized former President Donald Trump for severe unemployment during his tenure, as well as his economic policies and handling of t
Cannabis Use Linked To Improved COVID-19 Outcomes, New Study Suggests
Explore how the latest study suggests cannabis use linked to improved COVID-19 outcomes, highlighting potential health benefits.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Here's a look at five stocks that saw increased attention from Benzinga readers during the week and the reasons why.
Mark Zuckerberg's Admission Of Censorship A 'Beautiful Thing,' Says Vivek Ramaswamy: 'I Respect Him' For Admitting His Mistake
Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program
US households can order free COVID-19 tests starting in late September as the government reopens the program ahead of the fall virus season.
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to match current variants and will be available soon.
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating the condition affecting millions of Americans. Researchers continue to explore more specialized testing.
Markets Experience Best And Worst Days Since 2022: What's Next In Wall Street's Rollercoaster Ride?
Volatility spiked due to weak jobs report, yen carry trade collapse, and recession fears. Investors brace for similar price action and macro uncertainties.
Mark Zuckerberg's Meta Platforms Triumphs Over Independent Presidential Candidate Robert Kennedy Jr.'s Anti-Vaccine Group In Censorship Lawsuit
Meta Platforms successfully defended against an appeal by Children's Health Defense, with the 9th U.S. Circuit Court ruling that the group failed to prove Meta was coerced by federal officials to suppress anti-vaccine views.
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected by Sept.
Biden Gets COVID-19, Takes A Fiesty Dig At Tesla CEO: 'I'm Sick …Of Elon Musk And His Rich Buddies Trying To Buy This Election'
DraftKings Offers $10K Prediction Pool For Trump, Biden Presidential Debate: 11 Questions About Immigration, Inflation, Putin And More
A highly anticipated presidential debate on Thursday will see Donald Trump and President Joe Biden go head-to-head on key topics ahead of the 2024 election.
Marjorie Taylor Greene Promises To 'Lock Up' Anthony Fauci For Handling Of Pandemic: 'Should Be Tried For Crimes Against Humanity'
Republican Representative Marjorie Taylor Greene made a commitment to put every effort into prosecuting Dr. Anthony Fauci.
Mark Cuban Uses Hypothetical Space Virus Spread By Star Trek Aliens On Mars To Make A Point About Vaccines To Elon Musk
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved